// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Predicting Alzheimer’s disease progression in healthy and MCI subjects using multi-modal deep learning approach

Ghazal Mirabnahrazam - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mild cognitive impairment

N/A

The altered fractional amplitude of low-frequency fluctuations (fALFF) signals and the correlation between ROI-based fALFF and local amyloid-b deposition in high-risk population-T2DM and SCD

Yiwen Bao - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Dyslipidemia

N/A

- Longitudinal evolution of neuropathological substrates of Alzheimer’s disease in obese patients

Paul Edison - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mild cognitive impairment

N/A

- Is cortical grey matter diffusivity an early biomarker for neuronal damage?

Paul Edison - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mild cognitive impairment

N/A

- Colocalization of cortical diffusivity changes and microglial activation in dementia

Paul Edison - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mild cognitive impairment

N/A

- Concerted alterations of functional connectivity and WM integrity in relationship to early amyloid deposition

Luigi Lorenzini - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

- Increased pro-inflammatory plasma markers are associated with a longitudinal decrease in left hippocampal volumes in MCI patients

James Breese - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Association between the estimated 10-year cardiovascular mortality risk and cognitive function in older adults: results from the FINGER trial

Ruth Stephen - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

- Subiculum fiber degeneration within the fornix white matter tract in 5xFAD mice

Michael S Bienkowski - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

CSF sTREM2 has opposite association with brain structural damage rate at early and late stage of Alzheimer’s disease

Fangda Leng - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

Regulatory T cells decrease A1-like C3-positive reactive astrocytes in Alzheimer-like pathology

Grégoire Stym-Popper - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The gut microbe-derived methylamine TMAO protects against neuroinflammation through restraint of pro-inflammatory glial behaviour

Simon McArthur - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

- Microglial proteins Iba1 and TSPO (PBR) are differentially altered in the temporal cortex and cerebellum according to Braak stage.

Emma F Garland - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

- Phonemic restoration in Alzheimer's disease and semantic dementia

Jessica Jiang - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

- Processing of acoustically degraded speech in primary progressive aphasia and Alzheimer's disease

Jessica Jiang - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

- Processing of acoustically degraded emotional prosody in primary progressive aphasia and Alzheimer's disease

Jessica Jiang - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

A machine learning-based quality control tool for functional MRI images

Luis R Peraza - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

- Evidence for functional connectivity pattern changes in Frontotemporal dementia patients using connectome gradient mapping

Arabella Bouzigues - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Frontotemporal dementia

N/A

- Vessel distance mapping: a novel methodology for assessing vascular-induced cognitive resilience

Berta Garcia-Garcia - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Cerebral small vessel disease

N/A

- How many is enough? Sample size estimation for imaging-based outcomes in clinical trials of neurodegenerative disease

David M Cash - Alzheimer's Association International Conference (AAIC) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved